4.6 Article

Amaryllidaceae-Type Alkaloids from Pancratium maritimum: Apoptosis-Inducing Effect and Cell Cycle Arrest on Triple-Negative Breast Cancer Cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

The Roles of microRNAs in Cancer Multidrug Resistance

Lucia Pavlikova et al.

Summary: This paper provides an overview of the possible role of miRNAs in the molecular mechanisms that lead to multidrug resistance (MDR). miRNAs regulate post-transcriptional processes in the proteosynthetic pathway and may serve as specific effectors or interesting targets for cancer therapy.

CANCERS (2022)

Article Chemistry, Medicinal

Alkylated monoterpene indole alkaloid derivatives as potent P-glycoprotein inhibitors in resistant cancer cells

David S. P. Cardoso et al.

Summary: This study aimed to enhance multidrug resistance (MDR) reversing activity in cancer by deriving new compounds from major epimeric alkaloids isolated from Tabernaemontana elegans. The derivatives showed increased activity, with those containing N-phenethyl moieties exhibiting the strongest P-glycoprotein inhibitory effects. Synergistic interactions with the antineoplastic drug doxorubicin were observed, highlighting the potential of these compounds as MDR reversers. Lipophilicity and bulkiness features were associated with inhibitory activity based on the explored QSAR models.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2021)

Review Biochemistry & Molecular Biology

Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment

Tai-Na Wu et al.

Summary: Triple-negative breast cancer is typically treated with chemotherapy, but drug resistance often leads to poor prognosis. Abnormal tumor metabolism and immune cells in the tumor microenvironment may impact tumor growth and resistance to treatment. Phytochemicals have the potential to alter tumor metabolism and reprogram the tumor microenvironment, potentially suppressing cancer metastasis and overcoming chemoresistance.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Pharmacology & Pharmacy

BBIT20 inhibits homologous DNA repair with disruption of the BRCA1-BARD1 interaction in breast and ovarian cancer

Liliana Raimundo et al.

Summary: The study demonstrates that BBIT20, a natural compound, inhibits homologous DNA repair in triple-negative breast and ovarian cancer cells, leading to DNA damage and apoptosis. BBIT20 shows significant antitumor activity in patient-derived cells and xenograft mouse models of ovarian cancer, with low toxicity in non-malignant cells and undetectable side effects in mice. Additionally, BBIT20 does not induce resistance and exhibits synergistic effects with cisplatin and olaparib in 2D and 3D models of these cancer cells.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

The Natural Products and Extracts: Anti-Triple-Negative Breast Cancer in Vitro

Han Chen et al.

Summary: TNBC, accounting for 15% to 20% of all BC cases, is one of the most challenging malignancies to treat, with chemotherapy being the main option. Natural compounds from marine and terrestrial sources have diverse structures and biochemical specificity, providing a compound library for discovering new drugs. Recent research has focused on natural products with strong anti-TNBC activities and their potential mechanisms from 2015 to 2021.

CHEMISTRY & BIODIVERSITY (2021)

Review Pharmacology & Pharmacy

The emerging role of immune checkpoint inhibitors in the treatment of triple-negative breast cancer

Sima Singh et al.

Summary: Triple-negative breast cancers are a heterogeneous group of breast carcinomas that do not express estrogen receptor, progesterone receptor, and epidermal growth factor receptor 2. Recent trials using immune checkpoint inhibitors for treatment have shown promising early results. This review provides an overview of immunotherapy-based treatments and discusses future opportunities for their use in TNBC.

DRUG DISCOVERY TODAY (2021)

Article Oncology

Cancer statistics for the year 2020: An overview

Jacques Ferlay et al.

Summary: The study briefly reviews the methods and data sources used in compiling the IARC GLOBOCAN cancer statistics for 2020 and summarizes the main results. It estimated that there were nearly 19.3 million new cancer cases and almost 10 million cancer deaths worldwide in 2020, with the most commonly diagnosed cancers being female breast cancer and lung cancer, and the most common causes of cancer death being lung cancer and liver cancer.

INTERNATIONAL JOURNAL OF CANCER (2021)

Review Biochemistry & Molecular Biology

The Influence of Cell Cycle Regulation on Chemotherapy

Ying Sun et al.

Summary: Cell cycle regulation is crucial for cell proliferation, growth, and repair, and closely related to tumor occurrence and development. Chemotherapy can synergize with cell cycle regulation to improve sensitivity of tumor cells to chemotherapeutic drugs in cancer treatment. Collaborative strategies of chemotherapy and cell cycle regulation are discussed, along with challenges and perspectives for improving combination strategies for cancer therapy.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Review Oncology

Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance

Christiana M. Neophytou et al.

Summary: This review discusses the deregulation of apoptotic pathways as a key factor leading to multidrug resistance (MDR) in cancer cells, along with the impact of the tumor microenvironment on apoptosis in MDR tumors. Therapeutic approaches targeting Bcl-2 family members, IAPs, and AKT, as well as the potential of epigenetic modifications in reversing MDR, are highlighted as important strategies against drug resistance.

CANCERS (2021)

Article Chemistry, Medicinal

Exploring the Monoterpene Indole Alkaloid Scaffold for Reversing P-Glycoprotein-Mediated Multidrug Resistance in Cancer

David S. P. Cardoso et al.

Summary: The study reported a monoterpene indole alkaloid Dregamine isolated from Tabernaemontana elegans, which underwent chemical transformations to produce azines and semicarbazones with various substituents. These derivatives exhibited potent multidrug resistance (MDR) reversal activity, especially those containing aromatic substituents in the azine moieties.

PHARMACEUTICALS (2021)

Review Biotechnology & Applied Microbiology

Current status and contemporary approaches to the discovery of antitumor agents from higher plants

Garima Agarwal et al.

BIOTECHNOLOGY ADVANCES (2020)

Review Biochemistry & Molecular Biology

Overcoming multidrug resistance in cancer: Recent progress in nanotechnology and new horizons

Maryam Majidinia et al.

IUBMB LIFE (2020)

Review Plant Sciences

Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019

David J. Newman et al.

JOURNAL OF NATURAL PRODUCTS (2020)

Article Pharmacology & Pharmacy

Epoxylathyrane Derivatives as MDR-Selective Compounds for Disabling Multidrug Resistance in Cancer

Mariana Alves Reis et al.

FRONTIERS IN PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

Nitrogen-containing naringenin derivatives for reversing multidrug resistance in cancer

Ricardo J. Ferreira et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2020)

Article Biochemistry & Molecular Biology

Monoterpene indole alkaloid azine derivatives as MDR reversal agents

Angela Paterna et al.

BIOORGANIC & MEDICINAL CHEMISTRY (2018)

Article Chemistry, Medicinal

Optimizing the flavanone core toward new selective nitrogen-containing modulators of ABC transporters

Ricardo J. Ferreira et al.

FUTURE MEDICINAL CHEMISTRY (2018)

Article Pharmacology & Pharmacy

Improving anticancer activity towards colon cancer cells with a new p53-activating agent

Liliana Raimundo et al.

BRITISH JOURNAL OF PHARMACOLOGY (2018)

Article Chemistry, Medicinal

Dregamine and tabernaemontanine derivatives as ABCB1 modulators on resistant cancer cells

Angela Paterna et al.

EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)